Burkitt Lymphoma

Description

Burkitt lymphoma is a rare form of malignant mature B-cell non-Hodgkin lymphoma.

Clinical Features

Top most frequent phenotypes and symptoms related to Burkitt Lymphoma

  • Neoplasm
  • Immunodeficiency
  • Abdominal pain
  • Abnormality of the liver
  • Nausea and vomiting
  • Lymphoma
  • Gastrointestinal hemorrhage
  • Intestinal obstruction
  • Hyperuricemia
  • B-cell lymphoma

And another 9 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Based on the latest data available BURKITT LYMPHOMA have a estimated incidence of 0.17 per 100k worldwide.
No data available about the known clinical features onset.

Alternative names

Burkitt Lymphoma Is also known as small non-cleaved cell lymphoma.

Researches and researchers

Doctors, researchs, and experts related to Burkitt Lymphoma extracted from public data.

Burkitt Lymphoma Experts map



Current Researchs and researchers

  • VILLEJUIF — Dr Laurence BRUGIERES

    Clinical geneticist - Investigator of research project

    • Institution/s:
      — CLCC Institut Gustave Roussy
      — CLCC Institut Gustave Roussy
    • Research area/topic::

      Study on the Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents


  • ULM — Pr Reiner SIEBERT

    Clinical expert - Clinical geneticist - Investigator of research project - Coordinator of research network - Director of department

    • Institution/s:
      — Universitätsklinikum Ulm
    • Research area/topic::

      Malignant Lymphoma - Germinal center B-cell derived lymphomas - Project contributes to the International Cancer Genome Consortium (ICGC)


  • WÜRZBURG — Pr Andreas ROSENWALD

    Responsible for diagnostic tests - Investigator of research project - Manager of biobank/collection - Director of laboratory

    • Institution/s:
      — Institut für Pathologie der Universität Würzburg
    • Research area/topic::

      Molecular pathogenesis of malignant B cell lymphoma


  • GENOVA — Dr Giovanna CUTRONA

    Investigator of research project

    • Institution/s:
      — Oncologia Medica, Istituto Nazionale per la Ricerca sul Cancro - IST
    • Research area/topic::

      Burkitt's lymphoma: relevance to therapy and prevention. Study of therapies in mouse animal models


  • PERUGIA — Pr Cristina MECUCCI

    Clinical expert - Responsible for diagnostic tests - Investigator of research project - Director of laboratory - Quality manager

    • Institution/s:
      — Università degli Studi di Perugia - Ospedale S. Maria della Misericordia
    • Research area/topic::

      Characterization of chromosomal breakpoints in hematological malignancies using molecular cytogenetics



Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Burkitt Lymphoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Detection by FISH of C-MYC (8q24) rearrangements.

By CGC Genetics (Portugal).

MYC
Specificity
100 %
Genes
100 %
Detection by FISH of t(8;14) MYC/IGH.

By CGC Genetics (Portugal).

IGH, MYC
Specificity
50 %
Genes
100 %
Cancer Hotspot Panel.

By Centogene AG - the Rare Disease Company (Germany).

BCL6, ROS1, BRAF, BRCA1, BRCA2, SMARCB1, SMO, SRC, STK11, HNF1A, TP53, TSC1, TSC2, VHL, EML4, BRD4, CCND1, CCNE1, FBXW7, CD74 , (...)

View the complete list with 68 more genes
Specificity
2 %
Genes
100 %
Fluorescent in situ Hybridization - Hematopathology.

By Hartford Hospital Laboratory - Molecular Genetics and Cytogenetics Hartford Hospital-Hartford-CT-USA (United States).

BCL6, BCR, RUNX1, ABI1, TCF3, TP53, DLEU1, CRLF2, RUNX1T1, CBFB, CDKN2A, CDKN2C, CKS1B, ETV6, MECOM, FGFR1, IGH, JAK2, MYC, ABL1 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
100 %
FISH, Lymphoma Panel.

By Cytogenetics and Molecular Pathology Laboratory UP Health System Marquette (United States).

BCL6, CCND1, IGH, MALT1, MYC
Specificity
20 %
Genes
100 %
MYC.

By Fulgent Genetics Fulgent Genetics (United States).

MYC
Specificity
100 %
Genes
100 %
Onco microarray for CLL.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center (United States).

BCL6, TP53, BCL11A, CCND1, FGF2, AKT1, ALK, IGH, ITK, MYB, MYBL1, MYC, ATM, BCL10, BCL3
Specificity
7 %
Genes
100 %
Focus::DLBCL&FL™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. (United States).

BCL6, SGK1, BRAF, ARID1A, BTK, STAT3, STAT6, SYK, TNFAIP3, FAS, TP53, IKZF1, IKZF3, CARD11, CD79A, CD79B, CDKN2A, CDKN2B, SOCS1, CREBBP , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
100 %

We have 18 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCHIZENCEPHALY VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1 SYNPOLYDACTYLY 2; SPD2 PITUITARY STALK INTERRUPTION SYNDROME GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more